canakinumab
novartis
['canakinumab']
61pts with #fmf on canakinumab - single center in turkey
35% no attacks
attack frequency decreased in 55%
no response in 10%
- vas score and inflammatory markers significantly improved
#acr22 abst#1834
Rheumatologist @HSpecialSurgery @WeillCornell ClinicalResearch | Big Data | Outcomes | Epidemiology | Disparities | Table tennis player | Tweets are my own.